The treatment patterns, efficacy, and safety of nabĀ®-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis
Crossref DOI link: https://doi.org/10.1186/s12885-015-2027-x
Published Online: 2015-12-29
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liang, Caihua
Li, Ling
Fraser, Cindy Duval
Ko, Amy
Corzo, Deyanira
Enger, Cheryl
Patt, Debra
License valid from 2015-12-01